Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 3, 2026PharmacoEconomics - OpenOpen Access

Subcutaneous Ocrelizumab for the Treatment of Relapsing Forms of Multiple Sclerosis: A Budget Impact Model

View Full Paper
Ask AI
Bookmark
Share

Authors

CPCamilla PortaPPPaolo Di ProcoloGMGiuseppina Marrazzo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Porta et al. (2026) studied this question.

synapsesocial.com/papers/6a72dbc15d387586d7543b59https://doi.org/10.1007/s41669-026-00672-9
View Full Paper
Ask AI
Bookmark
Share